Learn more about whether Amarin Corporation plc or Catalyst Pharmaceuticals, Inc. is a better investment based on AAII's A+ ...

We recently published a list of 11 Best Russell 2000 Stocks to Buy According to Wall Street Analysts. In this article, we are ...

Health Canada granted priority review to an application seeking approval of vamorolone, marketed in the U.S. as Agamree, for Duchenne MD.

Catalyst Pharmaceuticals (NasdaqCM:CPRX) saw a minor decline of 3% over the past month amidst a backdrop of broader market volatility triggered by new tariffs and economic uncertainties. Despite the ...

Catalyst Pharmaceuticals (CPRX) reported that its sub-licensee in Canada, Kye Pharmaceuticals, has announced that Health Canada has accepted ...

VALLETTA, Malta, April 08, 2025 (GLOBE NEWSWIRE) -- Leading B2B software provider Delasport is powering up A247's iGaming ...

Kye Pharmaceuticals announced it has submitted a New Drug Submission, or NDS, to Health Canada for the regulatory review and approval of ...

Kye Pharmaceuticals, Inc. ("Kye") announced today it has submitted a New Drug Submission (NDS) to Health Canada for the ...

Dario Eklund, CEO of Santhera said: “The last 12 months have been a pivotal period for both the Company and DMD patients, as we began the global commercial roll-out of AGAMREE. Today, we are pleased ...

Her experience would be invaluable as we continue the rollout of AGAMREE® in new markets and evaluate opportunities to further expand our portfolio. Dr. Rolli's nomination follows the recent ...

Her experience would be invaluable as we continue the rollout of AGAMREE® in new markets and evaluate opportunities to further expand our portfolio. Dr. Rolli’s nomination follows the recent ...